FluxMPS™ Basal Medium Eagle (BME), 25mM HEPES w/o Sodium Bicarbonate: 1X Liquid
FluxMPS™ Basal Medium Eagle (BME), 25mM HEPES w/o Sodium Bicarbonate: 1X Liquid is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) cell culture medium buffered with 25 mM HEPES and formulated without sodium bicarbonate, engineered for organ-on-a-chip (OoC), tissue-on-a-chip (ToC), and microphysiological system (MPS) applications. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration.
- Quadruple-stage filtration train: 0.1 µm (Prefiltration I) → 0.04 µm (Final filtration I) → 0.1 µm (Prefiltration II) → 0.04 µm (Final filtration II — Polish)
- Endotoxin release specification: < 0.05 EU/mL (LAL assay, USP <85> BET)
- 25 mM HEPES buffering with no added sodium bicarbonate — pH stability in ambient air, reduced CO2 dependency
- Contains 1.0 g/L D-glucose and 292 mg/L L-glutamine; sodium pyruvate not added
- Manufactured under an ISO 13485:2016 quality management system; final fill & finish at Diagnocine, Totowa, NJ
- Prepared with Type 1 water (18.2 MΩ·cm) for trace-metal and organic-carbon (TOC) control
- Available in 500 mL and 1000 mL pack sizes
- Custom pH, glucose, salts, HEPES, and nutrient composition available on request — contact support@diagnocine.com
- Glucose1000 mg/L (1.0 g/L)
- L-Glutamine292 mg/L
- Sodium PyruvateNot added
- HEPES5958 mg/L (25 mM)
- pH (USP <791>)7.4
- Osmolality (USP <785>)280 - 320 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2
- Storage2–8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
Engineered where standard media fails
Conventional 0.22 µm-filtered media carry mycoplasma-sized particulates (0.2–0.3 µm), subvisible debris, and endotoxin variability that accumulate inside microchannels — corrupting biosensor readings and shortening device lifetimes. FluxMPS™ addresses these failure modes with a validated four-stage filtration train.
Microchannel-safe purity
0.04 µm final filter stage retains particles down to sub-mycoplasma size (0.2–0.3 µm); USP <788> Method 1 (light obscuration) particulate compliance verified per lot.
Total metabolic control
This formulation supplies 1.0 g/L D-glucose and 292 mg/L L-glutamine as defined carbon and nitrogen sources. Glucose-free custom formulations are available on request for Warburg-effect and metabolic flux studies.
Ultrapure-grade water
Prepared with Type 1 water (18.2 MΩ·cm), controlled for trace metals and organic carbon (TOC) to minimize background contribution from the aqueous base.
Low background for imaging
Ultra-low particulate baseline supports confocal microscopy and live-cell biosensor workflows. Note: this formulation contains phenol red, which absorbs in the visible range; a phenol red-free variant is available on request for fluorescence-sensitive assays.
Rich, stable nutrient profile
Micro-batch manufacturing supports consistent lot-to-lot amino acid and vitamin concentrations for reproducible long-term perfusion studies.
Customization on demand
pH, glucose concentration, salts, HEPES, and full nutrient composition available on request. Contact support@diagnocine.com.
Quadruple-stage filtration system
FluxMPS™ Basal Medium Eagle (BME), 25mM HEPES w/o Sodium Bicarbonate: 1X Liquid is a ready-to-use formulation processed through a four-stage serial filtration sequence that reaches 0.04 µm — addressing mycoplasma-sized organisms (0.2–0.3 µm) and subvisible particulates that 0.22 µm filtration cannot retain.
-
1
0.1 µm Prefiltration I
Removes large particulates, cell debris, and protein aggregates; protects the first 0.04 µm final-filter cartridge.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates and microaggregates that pass through a 0.22 µm filter.
-
3
0.1 µm Prefiltration II
Second dedicated prefilter, protecting the second 0.04 µm final-filter cartridge and providing redundancy across the train.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter; aseptic fill & finish performed in an ISO Class 5 (Class 100) laminar-flow workstation.
Performance vs. conventional media
By reaching a 0.04 µm final pore size across four sequential stages (two prefilter/final-filter pairs), FluxMPS™ delivers approximately 5× cleaner media by particulate count compared to single-pass 0.22 µm filtration.
© Diagnocine® — DCP-BMEH-B1X
Designed for next-generation cell culture platforms
FluxMPS™ Basal Medium Eagle (BME), 25mM HEPES w/o Sodium Bicarbonate: 1X Liquid is validated for use across organ-on-a-chip, metabolic research, live-cell imaging, and primary cell models where particulate contamination and endotoxin variation are unacceptable.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant is available for automated bioreactor and robotic perfusion systems requiring the ultimate particulate exclusion.
- Total Particulate Exclusion: 10 nm filtration for nanoscale valve and sensor protection
- Valve & Sensor Protection: reduces risk of particulate-induced blockage in precision fluidic systems
- Extended Perfusion Stability: supports flow rate consistency across multi-week automated runs
Inquiry Required: The 0.01 µm MPS Grade variant is available by special order. Contact support@diagnocine.com to request this variant.
Micro Physiological System (MPS) & Chip
Ultra-filtered formulation helps prevent microchannel clogging and supports laminar flow integrity across complex chip geometries.
Warburg Effect & Metabolic Research
Defined carbon source and controlled endotoxin background support metabolic flux analysis and Warburg effect studies.
iPSC-Derived Models
Ultra-filtered formulation supports sensitive iPSC differentiation protocols where endotoxin and particulates cause off-target effects.
Endothelial & Primary Cells
Microchannel-safe purity supports endothelial barrier integrity and TEER measurements in perfusion models.
Metabolic Flux Analysis
Defined glucose and glutamine concentrations support isotope tracing and metabolic flux workflows. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red-free medium.
Microscopy & Optical Sensing
Ultra-low particulate load supports high-content confocal imaging and optical biosensor integration.
Lot-release quality parameters
Every production lot of FluxMPS™ Basal Medium Eagle (BME), 25mM HEPES w/o Sodium Bicarbonate: 1X Liquid undergoes the complete quality-release battery listed below before shipment.
| Parameter | Specification |
|---|---|
| Formulation | L-Glutamine + Phenol Red + HEPES + Calcium + Magnesium + Glucose; without Sodium Bicarbonate, without Sodium Pyruvate |
| Appearance | Red-colored, clear solution |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 280 - 320 mOsm/kg H2O |
| Glucose | 1000 mg/L (1.0 g/L) |
| L-Glutamine | 292 mg/L |
| Sodium Pyruvate | Not added |
| Phenol Red | Present (11.000 mg/L) |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL |
| Sterility USP <71> | No growth after 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | Compliant |
| Particulate ≥25 µm USP <788> Method 1 | Compliant |
| Water Purity | Ultrapure Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 ISO 13485 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, protected from light |
| Freeze-thaw | Not recommended |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | HEPES-buffered — reduced CO2 dependency |
| Parameter | Specification |
|---|---|
| Raw material grade | Cell culture / reagent grade |
| Traceability | Full lot documentation, CoA available |
| Manufacturing QMS | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch precision manufacturing |
| Available pack sizes | 500 mL, 1000 mL |
| Intended use | For Research Use Only (RUO) |
Full composition (mg/L)
Complete formulation with CAS numbers. All ingredient names and mg/L values are reproduced from the manufacturer specification. Total: 30 components across 4 categories (Inorganic Salts, Amino Acids, Vitamins, Others). Custom compositions available on request.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium chloride | 7647-14-5 | 6800.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 122.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| L-Arginine hydrochloride | 1119-34-2 | 21.100 |
| L-Cystine dihydrochloride | 30189-89-0 | 15.650 |
| L-Glutamine | 56-85-9 | 292.000 |
| L-Histidine hydrochloride | 1007-42-7 | 10.500 |
| L-Isoleucine | 73-32-5 | 26.200 |
| L-Leucine | 61-90-5 | 26.200 |
| L-Lysine hydrochloride | 657-27-2 | 36.480 |
| L-Methionine | 63-68-3 | 7.500 |
| L-Phenylalanine | 63-91-2 | 16.500 |
| L-Threonine | 72-19-5 | 23.800 |
| L-Tryptophan | 73-22-3 | 4.000 |
| L-Tyrosine disodium salt | 69847-45-6 | 25.950 |
| L-Valine | 72-18-4 | 23.400 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 1.000 |
| D-Biotin | 58-85-5 | 1.000 |
| D-Ca-Pantothenate | 137-08-6 | 1.000 |
| Folic acid | 59-30-3 | 1.000 |
| Nicotinamide | 98-92-0 | 1.000 |
| Pyridoxal hydrochloride | 65-22-5 | 1.000 |
| Riboflavin | 83-88-5 | 0.100 |
| Thiamine hydrochloride | 67-03-8 | 1.000 |
| i-Inositol | 87-89-8 | 2.000 |
| OTHERS | ||
| D-Glucose | 50-99-7 | 1000.000 |
| HEPES | 7365-45-9 | 5958.000 |
| Phenol red sodium salt | 34487-61-1 | 11.000 |
ISO 13485:2016 manufacturing & compliance
FluxMPS™ Basal Medium Eagle (BME), 25mM HEPES w/o Sodium Bicarbonate: 1X Liquid is manufactured under a full ISO 13485:2016 quality management system, with final packaging, testing, and customization completed at Diagnocine in Totowa, New Jersey, USA.
ISO 13485:2016 QMS
Full quality management system certification covering manufacturing, testing, and release processes for every production lot.
Ultrapure Type 1 Water
All media prepared with 18.2 MΩ·cm resistivity Type 1 water, controlled for trace metals and organic carbon (TOC).
ISO Class 5 Fill & Finish
Aseptic filling performed in validated laminar-flow (ISO Class 5 / Class 100) workstations; 21 CFR Part 820 (QMSR) aligned.
Micro-Batch Precision
Small-batch manufacturing supports consistent lot-to-lot nutrient concentrations for reproducible perfusion studies and long-term OoC experiments.
Endotoxin — USP <85> BET
LAL assay performed per batch. Release specification: < 0.05 EU/mL. See the batch-level quality control note below.
Particulate — USP <788> Method 1
Light obscuration particle count test confirms ≥10 µm and ≥25 µm particulate compliance on every lot.
Osmolality — USP <785>
Freezing-point osmometry performed per USP <785>. Result: 280 - 320 mOsm/kg H2O.
Documentation — CoA & Full Lot Records
Certificate of Analysis available for every lot, including full QC panel, raw material traceability, and release signatures.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-BMEH-B1X (FluxMPS™) compares
Side-by-side comparison against conventional 0.22 µm-filtered alternatives of the same base formulation.
| Parameter | DCP-BMEH-B1X (FluxMPS™) | Conventional BME (0.22 µm) | Standard BME alternative |
|---|---|---|---|
| Grade | Microfluidics Suitable (0.04 µm final) | Not specified | Not specified |
| Buffering system | HEPES-buffered (25 mM), bicarbonate-free | Sodium bicarbonate-buffered | Sodium bicarbonate-buffered |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 stages | 1 stage | 1–2 stages |
| Mycoplasma barrier filtration | check_circle | cancel | cancel |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL | Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
| USP particulate compliance | check_circle USP <788> | cancel | cancel |
| Water quality | Ultrapure Type 1 (18.2 MΩ) | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | Variable | Variable |
| Microfluidic channel compatibility | check_circle Validated | cancel Risk of clogging | cancel Risk of clogging |
| Custom formulation | check_circle On request | cancel | Limited |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ Basal Medium Eagle (BME), 25mM HEPES w/o Sodium Bicarbonate: 1X Liquid and Microfluidics Suitable cell culture media.
Supporting literature
Peer-reviewed publications supporting the scientific rationale for ultra-filtered media and microfluidic cell culture applications.
- Huh D et al. (2010). Reconstituting organ-level lung functions on a chip. Science, 328(5986), 1662–1668. doi:10.1126/science.1188302
- Bhatia SN & Ingber DE (2014). Microfluidic organs-on-chips. Nature Biotechnology, 32(8), 760–772. doi:10.1038/nbt.2989
- Bhattacharya S et al. (2018). Challenges in maintaining cell viability during microfluidic experiments. Electrophoresis, 39(7), 997–1006. doi:10.1002/elps.201700375
- Warburg O (1956). On the origin of cancer cells. Science, 123(3191), 309–314. doi:10.1126/science.123.3191.309
- Emmons EV (1965). Detection of mycoplasma in cell cultures using filtration. Proceedings of the Society for Experimental Biology, 118, 1010–1015. doi:10.3181/00379727-118-29988
- Kim S et al. (2012). Gut-on-a-chip microdevice replicates key functional features of the human intestine. Lab on a Chip, 12(12), 2165–2174. doi:10.1039/c2lc40074j
- Zhang YS et al. (2017). Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. PNAS, 114(12), E2293–E2302. doi:10.1073/pnas.1612906114
- Vernetti L et al. (2017). Functional coupling of human microphysiology systems. Scientific Reports, 7, 42296. doi:10.1038/srep42296
- Schuster B et al. (2020). Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids. Nature Communications, 11, 5271. doi:10.1038/s41467-020-19058-4
- Zheng F et al. (2021). Organ-on-a-chip systems: microengineering to biomimic living systems. Small, 17(7), 2004175. doi:10.1002/smll.202004175
